BAY 87-2243 1227158-85-1
Product Description
.cp_wz table {border-top: 1px solid #ccc;border-left:1px solid #ccc; } .cp_wz table td{border-right: 1px solid #ccc; border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;} .cp_wz table th {border-right: 1px solid #ccc;border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;}
Molecular Weight:
525.53 BAY 87-2243 is a potent and selective hypoxia-inducible factor-1 (HIF-1) inhibitor. Phase 1.
Biological Activity
BAY 87-2243 inhibits HIF-1 reporter gene activity and CA9 protein
expression with IC50 of 0.7 nM and 2 nM, respectively. In hypoxic lung
cancer H460 cells, BAY 87-2243 suppresses HIF target gene expression,
and inhibits HIF-1α protein accumulation. Under glucose depletion, BAY
87-2243 inhibits cell proliferation via interference with mitochondrial
function.
In H460 xenograft mouse model, BAY 87-2243 (4 mg/kg p.o.) reduces tumor
weight, HIF-1α protein, and HIF-1 target gene expression levels.
Method
To evaluate the cytotoxicity of BAY 87-2243, 2.000 cells of the
respective cell lines are seeded in 96-well plates and cultured in the
appropriate growth medium containing 10% FCS. BAY 87-2243 at various
concentrations is added at 24 h after seeding for additional 48 h and
cell viability is determined using Cell Titer Glow Assay.
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.
Chemical Information
Molarity Calculator
Dilution Calculator
Molecular Weight Calculator
Contact us if you need more details on BAY 87-2243. We are ready to answer your questions on packaging, logistics, certification or any other aspects about 1227158-85-1 BAY 87-2243、1227158-85-1. If these products fail to match your need, please contact us and we would like to provide relevant information.
Molecular Weight:
525.53 BAY 87-2243 is a potent and selective hypoxia-inducible factor-1 (HIF-1) inhibitor. Phase 1.
Biological Activity
BAY 87-2243 inhibits HIF-1 reporter gene activity and CA9 protein
expression with IC50 of 0.7 nM and 2 nM, respectively. In hypoxic lung
cancer H460 cells, BAY 87-2243 suppresses HIF target gene expression,
and inhibits HIF-1α protein accumulation. Under glucose depletion, BAY
87-2243 inhibits cell proliferation via interference with mitochondrial
function.
In H460 xenograft mouse model, BAY 87-2243 (4 mg/kg p.o.) reduces tumor
weight, HIF-1α protein, and HIF-1 target gene expression levels.
Method
To evaluate the cytotoxicity of BAY 87-2243, 2.000 cells of the
respective cell lines are seeded in 96-well plates and cultured in the
appropriate growth medium containing 10% FCS. BAY 87-2243 at various
concentrations is added at 24 h after seeding for additional 48 h and
cell viability is determined using Cell Titer Glow Assay.
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species | Baboon | Dog | Monkey | Rabbit | Guinea pig | Rat | Hamster | Mouse |
Weight (kg) | 12 | 10 | 3 | 1.8 | 0.4 | 0.15 | 0.08 | 0.02 |
Body Surface Area (m2) | 0.6 | 0.5 | 0.24 | 0.15 | 0.05 | 0.025 | 0.02 | 0.007 |
Km factor | 20 | 20 | 12 | 12 | 8 | 6 | 5 | 3 |
Animal A (mg/kg) = Animal B (mg/kg) multiplied by | Animal B Km |
Animal A Km |
For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.
Rat dose (mg/kg) = mouse dose (22.4 mg/kg) × | mouse Km(3) | = 11.2 mg/kg |
rat Km(6) |
Chemical Information
Molecular Weight (MW) | 525.53 |
---|---|
Formula | C26H26F3N7O2 |
CAS No. | 1227158-85-1 |
Storage | 3 years -20℃Powder |
---|---|
6 months-80℃in solvent (DMSO, water, etc.) | |
Synonyms | N/A |
Solubility (25°C) * | In vitro | DMSO | <1 mg/mL ( |
---|---|---|---|
Water | <1 mg/mL ( | ||
Ethanol | 8 mg/mL heating (15.22 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Chemical Name | 1-cyclopropyl-4-[4-[[5-methyl-3-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]-1H-pyrazol-1-yl]methyl]-2-pyridinyl]-piperazine |
---|
Molarity Calculator
Dilution Calculator
Molecular Weight Calculator
Contact us if you need more details on BAY 87-2243. We are ready to answer your questions on packaging, logistics, certification or any other aspects about 1227158-85-1 BAY 87-2243、1227158-85-1. If these products fail to match your need, please contact us and we would like to provide relevant information.
Product Categories : Epigenetics > HIF Inhibitor
Other Products
Hot Products
Astragaloside AChlortetracycline HCl 64-72-2Paclitaxel 33069-62-4Dexamethasone Acetate 1177-87-3Dinaciclib (SCH727965) 779353-01-4CHIR-124 405168-58-3Ro3280 1062243-51-9TAME 901-47-3CCG-1423 285986-88-110058-F4 403811-55-2Dabigatran (BIBR 953) 211914-51-1H 89 2HCl 130964-39-5T0901317 293754-55-9Aprepitant 170729-80-3Turofexorate Isopropyl (XL335) 629664-81-9BMS-378806 357263-13-9